SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹11.79 | ₹16.16 | ₹17.83 | ₹14.23 | ₹12.45 |
What is the latest Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹11.79 |
| Mar2024 | ₹16.16 |
| Mar2023 | ₹17.83 |
| Mar2022 | ₹14.23 |
| Mar2021 | ₹12.45 |
How is Earnings Per Share (EPS) of SUVEN PHARMACEUTICALS Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹11.79 | -27.04 | |
| Mar2024 | ₹16.16 | -9.37 | |
| Mar2023 | ₹17.83 | 25.30 | |
| Mar2022 | ₹14.23 | 14.30 | |
| Mar2021 | ₹12.45 | - | |
Compare Earnings Per Share (EPS) of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹13,655.0 Cr | 15.4% | 21.8% | -66% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | 15.4% |
21.8% |
-66% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses